The document discusses the move to cloud computing for regulated industries like pharmaceutical, biotech, and medical device companies. It notes that while 95% of people claim they don't use the cloud, they actually do for online banking, shopping, social media, and storing photos and music. The cloud provides benefits like high reliability, unlimited storage, easy sharing, and supporting enterprise software. However, regulated industries have additional requirements for cloud applications around authentication, encryption, compliance, auditing, and platform qualifications. Examples of potential cloud uses in pharma include drug discovery, clinical data collection, gene sequencing, and collaboration with partners. The future includes benefits like global accessibility, availability, and collaborative environments.